APOPTOTIC DEATH IN T LYMPHOCYTES
APOPTOTIC DEATH IN T LYMPHOCYTES
批准号:
6161054
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
该项目旨在评估半胱氨酸酶在T细胞死亡中的作用
一般说来。为了更好地研究它们的功能作用,我们有
开发了一种名为PhiPhiLux的新型荧光半胱氨酸酶底物,它可以
检测完整的凋亡细胞中caspase的激活情况。这种试剂是一种
聚腺苷二磷酸核糖caspase-3裂解位点衍生的多肽
含有两种罗丹明染料末端取代的聚合酶
使它们形成一种自猝灭的环状化合物
被蛋白水解性裂解破坏。细胞凋亡的提取物,但不是
正常胸腺细胞在DEVD后裂解这种底物,荧光
增加被caspase-3抑制剂选择性地阻断。PhiPhiLux可以
在体外被装载到完整的胸腺细胞中,并对凋亡做出反应
受刺激的胸腺细胞罗丹明含量随时间增加约10倍
用流式细胞仪进行荧光检测。这种染色增加是特别的
被caspase抑制剂zVAD-FMK预先孵育所阻断。双色
FITC-Annexin-V染色显示PhiPhiLux+细胞发生凋亡
从他们暴露的磷脂酰丝氨酸可以看出。共聚焦显微镜显示
PhiPhiLux染色是细胞质的,在T杂交瘤中用
星形孢菌素在线粒体psi丢失后以动力学方式出现。
在评估半胱氨酸酶在T细胞死亡中的一般重要性时,我们有
发现几乎所有的T细胞死亡都是由传统的
标准可被多肽-FMK半胱氨酸天冬氨酸氨基转移酶特异性抑制
抑制剂。这包括各种化疗药物的效果。
治疗T细胞肿瘤的药物。然而,由于对肿瘤细胞死亡的评估
体外可能与体内肿瘤根除无关,我们已经测试过
半胱氨酸天冬氨酸氨基转移酶抑制剂阻断各种药物的能力
减少软琼脂中菌落的形成。两者都使用
化疗药物和抗Fas,我们一直无法观察到
多肽-FMK或杆状病毒p35对本实验的阻断作用
半胱氨酸酶抑制剂,即使它们有效地阻止了传统细胞
同一实验中的死亡读数。我们目前正在尝试
确定这些差异是否是由于动力学的不同
两种类型的检测,或是否发生抑制集落形成
通过caspase非依赖的途径,即使在被Fas-
交联剂。
英文摘要
This project aims to assess the role of caspases in T cell death
generally. In order to better study their functional role, we have
developed a new fluorogenic caspase substrate termed PhiPhiLux which can
detect caspase activation in intact apoptotic cells. This reagent is a
peptide derived from the caspase-3 cleavage site of poly-ADP- ribose
polymerase containing two rhodamine dyes substituted at the ends of the
peptide so that they form a self-quenched cyclic compound which is
disrupted by proteolytic cleavage. Extracts from apoptotic but not
normal thymocytes cleave this substrate after DEVD, and the fluorescence
increase is selectively blocked by caspase- 3 inhibitors. PhiPhiLux can
be loaded into intact thymocytes in vitro, and in response to apoptotic
stimuli thymocytes undergo a time-dependent about 10x increase in rhodamine
fluorescence by flow cytometry. This staining increase is specifically
blocked by preincubation with the caspase inhibitor ZVAD-FMK. Two-color
staining with FITC- annexin-V shows that PhiPhiLux+ cells are apoptotic
as seen by their exposed phosphatidyl serine. Confocal microscopy shows
that the PhiPhiLux stain is cytoplasmic and in T hybridomas treated with
staurosporine appears kinetically after the loss of mitochondrial psi.
In assessing the general importance of caspases in T cell death, we have
found that virtually all T cell death which is apoptotic by traditional
criteria can be specifically inhibited by peptide-FMK caspase
inhibitors. This includes the effect of a variety of chemotherapeutic
agents on T cell tumors. However, since tumor cell death assessed in
vitro may not be relevant to in vivo tumor eradication, we have tested
the ability of caspase inhibitors to block the ability of various agents
to decrease the formation of colonies in soft agar. Using both
chemotherapeutic agents and anti-Fas, we have been unable to observe a
blocking effect in this assay by either peptide-FMK or baculovirus p35
caspase inhibitors, even though they efficiently block traditional cell
death readouts in the same experiment. We are currently attempting to
ascertain whether these differences are due to the different kinetics
of the two types of assay, or whether inhibiting colony formation occurs
by a caspase-independent pathway even when triggered by Fas-
crosslinking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6100954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3774389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:3962935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3774385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3962951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3752088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
海外基金